“The Expanding Opioid Crisis in Canada: Fighting Big Pharma”

Canada's opioid crisis is escalating, affecting communities and increasing homelessness and crime rates. Legal action is being taken against pharmaceutical companies.

The Expanding Opioid Crisis in Canada and the Fight Against Big Pharma

Canada, as many parts of the world, is in the throes of an opioid crisis that is escalating at an alarming rate. The sweeping effect of opioid addiction has bridged socioeconomic gaps and traversed geographical borders, stretching its devastating effects deep into the heart of communities. The stakeholders who can play a transformative role include civic and community leaders who are aware, engaged, and proactive in taking countermeasures against this burgeoning health catastrophe.

The Ripple Effects of the Opioid Crisis

Among the many alarming effects of the opioid crisis are the rising numbers of homeless individuals – a theme that has been consistently highlighted in the national conversation about opioids. The relationship between opioid abuse and homelessness is cyclic; substance use may initially lead to homelessness, and homelessness, in turn, exposes individuals to environments that encourage further substance abuse.

Beyond homelessness, rising crime rates, particularly of petty and property crimes, have been observed in areas heavily impacted by the opioid crisis. Moreover, pressures on law enforcement, emergency medical services, healthcare facilities, and social services have increased dramatically, draining public resources and creating a considerable strain on these essential infrastructures.

Combating the Opioid Crisis: A Call to Action

The sheer magnitude of the opioid crisis – underscored by the unnerving fact that opioid-related overdoses have become a leading cause of death among young Canadians – necessitates urgent and comprehensive interventions. A multipronged approach is called for that includes prevention, collaborative cross-sectoral treatment strategies, legal actions, and collaborative efforts with pharmaceutical companies to hold them accountable. One such trailblazing effort is currently underway in Canada, termed as the “Canadian opioid abatement class action“.

The Canadian Opioid Abatement Class Action

Pierre Poilievre, a Member of Parliament from Ontario, confirmed that his party will initiate a class action lawsuit against opioid manufacturers. This legal strategy aims to penalize pharmaceutical companies for their role in the opioid crisis, with the goal to fund treatment, prevention, and recovery efforts, making medications like naloxone more readily available. If successful, this would set a landmark precedent globally, and is likely to trigger a cascade of similar efforts worldwide.

Key Points:

  • The opioid crisis in Canada has led to increased homelessness and crime.
  • The strain on law enforcement, emergency medical services, healthcare facilities, and social services due to the opioid crisis is substantial.
  • Interventions to address the crisis need to be urgent and comprehensive, involving prevention, treatment strategies, and legal actions.
  • The Canadian opioid abatement class action seeks to hold pharmaceutical companies accountable for their role in the opioid crisis.


In conclusion, Canada’s opioid crisis presents a complex, multifaceted challenge that permeates society’s strata. The repercussions of opioid addiction are not isolated to substance abusers but extend to affect homelessness rates, crime, and the pressure on public resources and services. The Canadian opioid abatement class action, a collective legal effort, represents a tangible step towards holistically addressing and combating this crisis. This call to action impels pharmaceutical companies to assume responsibility for their role in propagating the opioid crisis, shining a beacon of hope in these challenging times.


Contact Us:

Please enable JavaScript in your browser to complete this form.
Scroll to Top